These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21179426)

  • 41. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.
    Heddleston JM; Li Z; McLendon RE; Hjelmeland AB; Rich JN
    Cell Cycle; 2009 Oct; 8(20):3274-84. PubMed ID: 19770585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy.
    Kemper K; de Goeje PL; Peeper DS; van Amerongen R
    Cancer Res; 2014 Nov; 74(21):5937-41. PubMed ID: 25320006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast-cancer stem cells-beyond semantics.
    Badve S; Nakshatri H
    Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
    Rossari F; Zucchinetti C; Buda G; Orciuolo E
    Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carcinogenesis is consequence of failure of tissue development.
    Lai S
    Med Hypotheses; 2018 Oct; 119():84-87. PubMed ID: 30122497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication.
    Trosko JE; Chang CC; Upham BL; Tai MH
    Ann N Y Acad Sci; 2004 Dec; 1028():192-201. PubMed ID: 15650245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A progenitor cell origin of myeloid malignancies.
    Haeno H; Levine RL; Gilliland DG; Michor F
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16616-21. PubMed ID: 19805346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study.
    Zhu X; Zhou X; Lewis MT; Xia L; Wong S
    J Theor Biol; 2011 Jan; 269(1):138-49. PubMed ID: 20969880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications.
    Ischenko I; Seeliger H; Kleespies A; Angele MK; Eichhorn ME; Jauch KW; Bruns CJ
    Langenbecks Arch Surg; 2010 Jan; 395(1):1-10. PubMed ID: 19421768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer?
    Enderling H; Hahnfeldt P
    Prog Biophys Mol Biol; 2011 Aug; 106(2):391-9. PubMed ID: 21473880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of cellular de-differentiation on the dynamics and evolution of tissue and tumor cells in mathematical models with feedback regulation.
    Wodarz D
    J Theor Biol; 2018 Jul; 448():86-93. PubMed ID: 29605227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy.
    Kruyt FA; Schuringa JJ
    Biochem Pharmacol; 2010 Aug; 80(4):423-30. PubMed ID: 20394737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic and metabolic regulation of breast cancer stem cells.
    Liu HX; Li XL; Dong CF
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.
    Liu X; Chen X; Rycaj K; Chao HP; Deng Q; Jeter C; Liu C; Honorio S; Li H; Davis T; Suraneni M; Laffin B; Qin J; Li Q; Yang T; Whitney P; Shen J; Huang J; Tang DG
    Oncotarget; 2015 Sep; 6(27):23959-86. PubMed ID: 26246472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer stem cells: problems for therapy?
    Alison MR; Lim SM; Nicholson LJ
    J Pathol; 2011 Jan; 223(2):147-61. PubMed ID: 21125672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer (stem) cell differentiation: An inherent or acquired property?
    Mohr M; Zänker KS; Dittmar T
    Med Hypotheses; 2015 Dec; 85(6):1012-8. PubMed ID: 26347071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications.
    Chen X; Liao R; Li D; Sun J
    Oncotarget; 2017 Mar; 8(10):17301-17312. PubMed ID: 28038467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Stem cells and cancer].
    Arvelo F; Cotte C; Sojo F
    Invest Clin; 2014 Dec; 55(4):371-91. PubMed ID: 25558756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?
    Sell S
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):15-26. PubMed ID: 7516873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer stem cell in breast cancer therapeutic resistance.
    Bai X; Ni J; Beretov J; Graham P; Li Y
    Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.